Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer-Reference-Cited by-同舟云学术

Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer

Published:2020-01-01 Issue:1 Volume:30 Page:42-56
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Masoodi Tariq¹,Siraj Abdul K.¹,Siraj Sarah¹,Azam Saud¹,Qadri Zeeshan¹,Albalawy Wafaa N.¹,Parvathareddy Sandeep Kumar¹,Al-Sobhi Saif S.²,Al-Dayel Fouad³,Alkuraya Fowzan S.⁴⁵,Al-Kuraya Khawla S.¹

Affiliation:

1. Human Cancer Genomic Research, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

2. Department of Surgery, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

3. Department of Pathology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

4. Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

5. Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2019.0052

Reference76 articles.

1. Thyroid cancer mortality and incidence: A global overview

2. New developments in the diagnosis and treatment of thyroid cancer

3. Prognostic effects ofTERTpromoter mutations are enhanced by coexistence withBRAForRASmutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients

4. BRAFV600E Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer

5. The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer;Cancer Cell International;2024-08-03

2. Association of BRAF V600E Mutant Allele Proportion with the Dissemination Stage of Papillary Thyroid Cancer;Biomedicines;2024-02-21

3. Genomic profiling of primary and metastatic thyroid cancers;Endocrine-Related Cancer;2023-11-28

4. In silico Screening and Validation of Achyranthes aspera as a Potential Inhibitor of BRAF and NRAS in Controlling Thyroid Cancer;Anti-Cancer Agents in Medicinal Chemistry;2023-11

5. Evidence that metastases arisede novoas new cancers from cells of target organs;2023-08-13